India's Bharat Biotech to produce additional 200 mln Covid-19 vaccine doses per year
The additional doses of the vaccine, called Covaxin locally, would be manufactured at the company's plant in Gujarat and would be available by the fourth quarter of 2021, the drugmaker said
Indian Health Minister Harsh Vardhan holds a dose of Bharat Biotech's COVID-19 vaccine called Covaxin, during a vaccination campaign at All India Institute of Medical Sciences (AIIMS) hospital in New Delhi, India, January 16, 2021. REUTERS/Adnan Abidi
India's Bharat Biotech on Thursday said it would ramp up the production of its Covid-19 vaccine by an additional 200 million doses per year.
The additional doses of the vaccine, called Covaxin locally, would be manufactured at the company's plant in Gujarat and would be available by the fourth quarter of 2021, the drugmaker said.
Keep updated, follow The Business Standard's Google news channel
